Obesity
In Episode 1, founder Su Robotti and editor Jonathan Block discuss the AspireAssist medical device.— “mechanized bulimia” or a useful obesity fighter? Su: Hi I am Su Robotti and I am the founder of MedShadow Foundation. This is Jonathan Block who is the content editor for MedShadow Foundation. We inform…
AspireAssist is essentially a pump that connects to a tube implanted in the stomach to suck food out. But is this a good way to achieve weight loss? Overweight Americans’ battle of the bulge has lasted decades, and every time a new diet, drug or device comes out claiming it…
The Food and Drug Administration (FDA) has approved a supplemental New Drug Application for Xenical (obesity management drug) regarding new drug interactions and adverse reaction updates to its labeling. Xenical is indicated for obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet. The…
Despite the disastrous outcomes of some diet drugs — including Redux (aka Fen-Phen) in 1996 and Meridia (Sibutramine) in 2003, the pharmaceutical industry keeps trying to find a safe, effective medication that will help the 160 million Americans considered obese or overweight lose weight. In the past 3 years, 5 drugs have been…
Good for you, India! Despite the fact that Pespi dangled $5 billion in front of India’s top officials, the country’s minister of food processing industries, Harsimrat Kaur Badal (pictured left), met with Pepsi’s chief executive, Indra Nooyi (who was herself born in India, though she is American now), to request…
Over the past six months, we at MedShadow Foundation have published the following information on the obesity epidemic: packaging of children’s food (BPA) might cause obesity, scientists have found a link but don’t yet understand the connection diabetics who lose weight are no less likely to have a heart attack,…
New FDA-approved drugs, novel devices, implants and surgical approaches have all hit the market but do they work and are they safe? The history of prescription diet drugs is littered with failures and safety scares. For example, in 1996 the pill Redux, which combined the two appetite suppressants fenfluramine and…
MedPages Today reports on a study published in the journal Pediatrics that ties obesity and a chemical found in packaging, BPA. BPA was one of two chemicals for packaging found in the urine of children. While BPA was linked with obesity, the other chemical, di-2-ethylhexyl phthalate (DEHP), was linked to…
